We are looking for a highly motivated, interactive individual to join a team of basic scientists and physicians whose aim is to develop potent new immune-based approaches for the treatment of cancer. We use mouse models to develop new treatments for patients with cancer. The focus of our present efforts is on adoptively transferring tumor-specific T lymphocytes. Current projects include Wnt and cytokine signaling in the activation and differentiation of T cell. Another focus is on the genetic manipulation of T cells with micro-RNAs, transcription factors, and cell surface molecules to enhance the functions of T cells.

Applicants should possess a Ph.D., M.D., or equivalent degree. The position involves the ability to discuss scientific data and strategy with diverse members of the team and with collaborators, so fluency in the English language is required. Candidates must have an excellent understanding of T cell immunology, a detailed knowledge of how to design and perform work using mice and skill at molecular biology. Candidates at an advantage for the position will know or be willing to learn how to construct retroviruses. The successful candidate will be in an excellent position to learn a wide variety of new techniques.

Location: NCI – Clinical Research Center – Bethesda.

The position is available immediately. The appointment duration is up to 5 years. Stipends are commensurate with education and experience.

Please click on the button below, or send a CV, 3 letters of reference, and a list of publications to:

Nicholas P Restifo, M.D.
Principal Investigator
National Cancer Institute
CRC Room 3-5762
Bethesda, MD 20892

Phone: (301) 496-4904
Fax: (301) 451-6949
E-mail: restifo@nih.gov


This position is subject to a background investigation.


The NIH is dedicated to building a diverse community in its training and employment programs.

To apply:

The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. Specifically, the Institute:

• Supports and coordinates research projects conducted by universities, hospitals, research foundations, and businesses throughout this country and abroad through research grants and cooperative agreements.
• Conducts research in its own laboratories and clinics.
• Supports education and training in fundamental sciences and clinical disciplines for participation in basic and clinical research programs and treatment programs relating to cancer through career awards, training grants, and fellowships.
• Supports research projects in cancer control.
• Supports a national network of cancer centers.
• Collaborates with voluntary organizations and other national and foreign institutions engaged in cancer research and training activities.
• Encourages and coordinates cancer research by industrial concerns where such concerns evidence a particular capability for programmatic research.
• Collects and disseminates information on cancer.
• Supports construction of laboratories, clinics, and related facilities necessary for cancer research through the award of construction grants.